MLchartDataset catalogue

omalizumab

Term · Oncology and biomedicine · MLC-T-ONC-015614

A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor.

Table 1. Record
IdentifierMLC-T-ONC-015614
FieldOncology and biomedicine
AbbreviationrhuMAb-E25
Synonymsanti-IgE monoclonal antibody E25; olizumab
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-015614",
  "term": "omalizumab",
  "field": "Oncology and biomedicine",
  "definition": "A humanized monoclonal antibody directed against the C-epsilon 3 domain of immunoglobulin E. Olizumab binds to this IgE domain, thereby preventing IgE from binding to its high-affinity mast-cell receptor.",
  "abbreviation": "rhuMAb-E25",
  "synonyms": [
    "anti-IgE monoclonal antibody E25",
    "olizumab"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/omalizumab/"
}

Record 12,162 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.